The University of Chicago Header Logo

Connection

Jeffrey Matthews to Adult

Back to Details
This is a "connection" page, showing publications Jeffrey Matthews has written about Adult.
Jeffrey Matthews
Connection Strength
0.291
Adult
  1. Gastric obstruction due to intramural pseudocyst associated with heterotopic pancreas. J Gastrointest Surg. 2014 Jun; 18(6):1225-6.
    View in: PubMed
    Score: 0.028
  2. Surgical management of pancreaticobiliary disease associated with juxtapapillary duodenal diverticula: case series and review of the literature. J Gastrointest Surg. 2012 Jul; 16(7):1436-41.
    View in: PubMed
    Score: 0.024
  3. Surgery and old age: an age old question. Arch Surg. 2009 Nov; 144(11):1020.
    View in: PubMed
    Score: 0.021
  4. The cost effectiveness of laparoscopic versus open gastric bypass surgery. Obes Surg. 2005 Jan; 15(1):24-34.
    View in: PubMed
    Score: 0.015
  5. Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer. Breast Cancer Res Treat. 2025 Feb; 209(3):487-492.
    View in: PubMed
    Score: 0.015
  6. Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial. Nat Med. 2024 Dec; 30(12):3728-3736.
    View in: PubMed
    Score: 0.014
  7. Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial. Nat Med. 2024 Dec; 30(12):3737-3747.
    View in: PubMed
    Score: 0.014
  8. Effectiveness of the uChicago Health Inequity Classification System on surgical morbidity and mortality conference: A pilot study. Am J Surg. 2024 Oct; 236:115834.
    View in: PubMed
    Score: 0.014
  9. Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial. Nat Commun. 2021 11 05; 12(1):6428.
    View in: PubMed
    Score: 0.012
  10. Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial. JAMA Oncol. 2021 Nov 01; 7(11):1654-1663.
    View in: PubMed
    Score: 0.012
  11. Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial. Cancer Cell. 2021 07 12; 39(7):989-998.e5.
    View in: PubMed
    Score: 0.011
  12. Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial. J Intern Med. 2021 04; 289(4):559-573.
    View in: PubMed
    Score: 0.011
  13. Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial. JAMA Oncol. 2020 09 01; 6(9):1355-1362.
    View in: PubMed
    Score: 0.011
  14. MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial. J Clin Oncol. 2020 04 01; 38(10):1059-1069.
    View in: PubMed
    Score: 0.010
  15. Early Infectious Complications After Total Pancreatectomy with Islet Autotransplantation: a Single Center Experience. J Gastrointest Surg. 2019 11; 23(11):2201-2210.
    View in: PubMed
    Score: 0.010
  16. Assessment of simple indices based on a single fasting blood sample as a tool to estimate beta-cell function after total pancreatectomy with islet autotransplantation - a prospective study. Transpl Int. 2019 03; 32(3):280-290.
    View in: PubMed
    Score: 0.010
  17. Pain Control, Glucose Control, and Quality of Life in Patients With Chronic Pancreatitis After Total Pancreatectomy With Islet Autotransplantation: A Preliminary Report. Transplant Proc. 2017 Dec; 49(10):2333-2339.
    View in: PubMed
    Score: 0.009
  18. Outcomes of Concurrent Operations: Results From the American College of Surgeons' National Surgical Quality Improvement Program. Ann Surg. 2017 09; 266(3):411-420.
    View in: PubMed
    Score: 0.009
  19. Preservation of beta cell function after pancreatic islet autotransplantation: University of Chicago experience. Am Surg. 2015 Apr; 81(4):421-7.
    View in: PubMed
    Score: 0.007
  20. Long-term outcomes after total pancreatectomy and islet cell autotransplantation: is it a durable operation? Ann Surg. 2014 Oct; 260(4):659-65; discussion 665-7.
    View in: PubMed
    Score: 0.007
  21. Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy. J Autoimmun. 2010 Jun; 34(4):408-15.
    View in: PubMed
    Score: 0.005
  22. Fistulojejunostomy for the management of refractory pancreatic fistula. Surgery. 2007 Oct; 142(4):636-42; discussion 642.e1.
    View in: PubMed
    Score: 0.004
  23. Intraoperative margin re-resection for colorectal liver metastases. J Surg Educ. 2007 May-Jun; 64(3):150-7.
    View in: PubMed
    Score: 0.004
  24. Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis. J Am Coll Surg. 2005 Nov; 201(5):680-7.
    View in: PubMed
    Score: 0.004
  25. An algorithm for the accurate identification of benign liver lesions. Am J Surg. 2004 Feb; 187(2):274-9.
    View in: PubMed
    Score: 0.003
  26. Total pancreatectomy and autologous islet cell transplantation as a means to treat severe chronic pancreatitis. J Gastrointest Surg. 2003 Dec; 7(8):978-89.
    View in: PubMed
    Score: 0.003
  27. Increased biliary fistulas after liver resection with the harmonic scalpel. Am Surg. 2003 Sep; 69(9):815-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.